Valley Brook Capital Group’s Chemours CC Stock Holding History

Valley Brook Capital Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$1K	–	154
2021 Q1	$1K	Hold	50	–	–	﹤0.01%	453
2020 Q4	$1K	Buy	+50	New	+$1.19K	﹤0.01%	389

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Valley Brook Capital Group's CC Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Chemours (CC) in Q2 2021, closing a stake of 50 shares — an estimated $1K sold.

Valley Brook Capital Group first reported a position in CC in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

Valley Brook Capital Group reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
Valley Brook Capital Group sold 50 Chemours shares in Q2 2021, an estimated $1K.
Valley Brook Capital Group first reported a position in Chemours in Q4 2020 and held it in 2 quarters.
Valley Brook Capital Group's Chemours position peaked at $1K in Q1 2021.
449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.